Quantcast

Latest Clinical trial Stories

2014-10-28 08:34:41

COSTA MESA, Calif., Oct. 28, 2014 /PRNewswire-iReach/ -- WCCT Global, a full Service Contract Research Organization headquartered in Southern California announced their involvement in a sentinel clinical trial designed to evaluate safety and immunogenicity signals from a novel oral vaccine for influenza, as opposed to injectable or intranasal vaccines. The study was first presented to the scientific community on October 14, 2014 at the World Vaccine Congress in Brussels, Belgium by...

2014-10-27 16:27:26

Innovative software uses genetic information to find the best treatment options for cancer patients HOUSTON, Oct. 27, 2014 /PRNewswire/ -- Today, MolecularMatch, Inc. announced it has launched its innovative software solution as an open Beta information service for oncologists and patients to easily connect cancer patients with the most appropriate FDA-approved treatments and clinical trials based on the molecular make-up of the patient's disease....

2014-10-27 08:27:57

Addition of Respected Clinical Trials Company Expands MPI Research Capabilities to Include Human Phase I Testing MATTAWAN, Mich., Oct. 27, 2014 /PRNewswire/ -- MPI Research today announced it has acquired the assets of Kalamazoo, Mich.-based Jasper Clinical Research & Development, Inc. Jasper is a respected clinical research organization that provides early-stage human clinical testing of promising new drugs, and is well known to pharmaceutical and biotechnology companies...

2014-10-24 08:26:25

Company CEO to present on October 28, 2014 JERUSALEM, October 24, 2014 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (http://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that the Company's CEO, Nadav Kidron will present at FireRock Capital's Micro-Cap Conference. Presentation Details: FireRock Capital's Annual Micro-Cap Conference Date:...

2014-10-23 08:36:17

Cite Barriers to Genetic Testing, Access to New Therapies as Thwarting Progress WASHINGTON, Oct. 23, 2014 /PRNewswire-USNewswire/ -- At a time when cancer drug development is at a critical juncture, accelerating the delivery of promising new treatments will depend on one critical requirement: ensuring that patients, individually and collectively, are actively involved in the cancer research and drug development process from beginning to end. This was the consensus of leading...

2014-10-23 04:21:52

BARCELONA, Spain, October 23, 2014 /PRNewswire/ -- Clients benefit from complete access, visibility, and control throughout the clinical trial inVentiv Health Clinical, a leading global supplier of drug development services, will replace its electronic trial master file (eTMF) content management system with Veeva Vault eTMF. Cloud-based, multitenant Vault eTMF delivers secure, instant access to inspection-ready documentation...

2014-10-22 20:23:18

LONDON, Oct. 22, 2014 /PRNewswire/ -- Chemotherapy Induced Peripheral Neuropathy Global Clinical Trials Review, H2, 2014 SummaryGlobalData's clinical trial report, "Chemotherapy Induced Peripheral Neuropathy Global Clinical Trials Review, H2, 2014" provides data on the Chemotherapy Induced Peripheral Neuropathy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Chemotherapy Induced Peripheral Neuropathy. It includes an...

2014-10-22 20:22:18

LONDON, Oct. 22, 2014 /PRNewswire/ -- Birch Pollen Allergy Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, "Birch Pollen Allergy Global Clinical Trials Review, H2, 2014" provides data on the Birch Pollen Allergy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Birch Pollen Allergy. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction...

2014-10-22 12:29:36

WASHINGTON, Oct. 22, 2014 /PRNewswire-USNewswire/ -- ALS ACT, The ALS Association, and the Translational Research Advancing Therapy ALS (TREAT ALS(TM)) Northeast ALS Consortium (NEALS) clinical trials network are pleased to announce a call for phase II clinical trial applications for novel, high-potential treatments in amyotrophic lateral sclerosis (ALS). The call for clinical study proposals is directed toward academic-industry partnerships, including pharmaceutical,...

2014-10-22 08:31:07

NORWALK, Conn., Oct. 22, 2014 /PRNewswire/ -- Recently published clinical studies of Stretta for gastroesophageal reflux disease (GERD) have bolstered the already substantial database of evidence. This data has led to significantly expanded insurance coverage and adoption of Stretta therapy for sufferers of refractory GERD. The substantial body of clinical evidence supporting Stretta therapy as a safe and effective GERD treatment has driven new coverage policies that make Stretta...


Word of the Day
barghest
  • A goblin in English folklore, often appearing in the shape of a large dog and believed to portend imminent death or misfortune.
  • A ghost, wraith, hobgoblin, elf, or spirit.
The origin of 'barghest' is not known, but it may be from perhaps burh-ghest, town-ghost, or German Berg-geist (mountain spirit) or Bär-geist (bear-spirit).
Related